素抑制严重急性呼吸系统综合征冠状病毒2复制 in vitro
Yethindra Vityala1, Tugolbai Tagaev2, Elmira Mainazarova3
1Department of Pathology, International Higher School of Medicine, International University of Kyrgyzstan, Bishkek, Kyrgyzstan.
Indian journal of pharmacology
|March 2, 2026
概括
这项研究表明,素显著抑制严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 在人类鼻腔细胞中的复制. 这为fluoxetine作为SARS-CoV-2感染的潜在治疗方法提供了早期证据.
科学领域:
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 目前没有有效的抗病毒药物用于严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 细胞进入或复制.
- 迫切需要针对SARS-CoV-2的新型治疗策略,需要探索现有的药物化合物.
研究的目的:
- 为了评估体内fluoxetine在抑制SARS-CoV-2复制的疗效.
- 评估素异构体对人类鼻上皮细胞中的病毒复制的影响.
主要方法:
- 对两种fluoxetine异构体进行了细胞毒性测试.
- 素对临床SARS-CoV-2分离物 (菌株IHUMI3) 复制的作用在人类鼻上皮细胞中进行了评估.
- 测量病毒标位和蛋白质表达以确定抗病毒活性.
主要成果:
- 素异构体在0.9微克/毫升时显著抑制了SARS-CoV-2,其半最大有效度 (EC50) 为0.39微克/毫升.
- 任何一种fluoxetine异构体的10μM度都将SARS-CoV-2标位降低了63.9%.
- 西治疗导致病毒蛋白表达的降低.
结论:
- 素有效地抑制了SARS-CoV-2在体外的复制.
- 这些发现表明,素是治疗SARS-CoV-2感染的潜在治疗剂.
- 进一步的研究是有必要的,以探索fluoxetine对SARS-CoV-2的临床应用.
相关概念视频
Influenza
101
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
101
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73


